Pfizer COVID-19 Vaccine: Pfizer has applied for emergency approval of its COVID-19 vaccine from the India's drugs controller, the DGCI. The vaccine has already been granted emergency-use authorisation in the UK and Bahrain. Sources tell NDTV that, though unprecedented, Pfizer vaccine can get emergency approval in the country even without conducting a clinical trial if the DCGI is satisfied with the foreign trial data submitted. Experts, however, maintain that the logistical concerns of storage at -70 degrees Celsius and the $20 cost make it difficult for India to get the vaccine anytime soon.
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
- Category
- Asia
- Tags
- NDTV 24x7, Coronavirus, coronavirus vaccine
Sign in or sign up to post comments.
Be the first to comment